Korean Pharma Q3 Roundup: Mixed Earnings, Taxotere Deal, R&D Advances

 
• By Jung Won Shin
  
third quarter review
Daewoong, SK Biopharm Among Solid Q3 Performers (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business